GO
Loading...

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 6:35 PM ET

    Baxter International Inc. rose$. 73 or 1.1 percent, to $69.83. Bristol-Myers Squibb Co. rose $1.13 or 2.2 percent, to $53.63. Hospira rose$. 80 or 1.6 percent, to $52.25.

  • Midday Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 1:17 PM ET

    Baxter International Inc. rose$. 64 or. 9 percent, to $69.74. Bristol-Myers Squibb Co. rose $1.00 or 1.9 percent, to $53.50. Hospira rose$. 48 or. 9 percent, to $51.93.

  • Early Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 10:40 AM ET

    Baxter International Inc. rose$. 67 or 1.0 percent, to $69.77. Bristol-Myers Squibb Co. rose $1.28 or 2.4 percent, to $53.78. Hospira rose$. 36 or. 7 percent, to $51.81.

  • Final Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 73 or 1.1 percent, to $69.10. Bristol-Myers Squibb Co. rose$. 66 or 1.3 percent, to $52.50. Hospira rose $1.37 or 2.7 percent, to $51.45.

  • Midday Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 1:51 PM ET

    Baxter International Inc. rose$. 72 or 1.1 percent, to $69.09. Bristol-Myers Squibb Co. rose$. 49 or. 9 percent, to $52.33. Hospira rose $1.12 or 2.2 percent, to $51.20.

  • Early Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 11:56 AM ET

    Baxter International Inc. rose$. 59 or. 9 percent, to $68.96. Bristol-Myers Squibb Co. rose$. 36 or. 7 percent, to $52.20. Hospira rose$. 74 or 1.5 percent, to $50.82.

  • Oct 23- Eli Lilly and Co said its quarterly earnings plunged 58 percent, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its earlier full-year profit forecast. The U.S. drugmaker on Thursday said it had earned $501 million, or 47 cents per share, in the third quarter. Sales fell 16 percent to $4.88 billion, but topped...

  • Lilly profit plunges as cheaper generics take toll Thursday, 23 Oct 2014 | 6:50 AM ET

    Oct 23- Eli Lilly and Co said its quarterly earnings plunged 58 percent, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its earlier full-year profit forecast. The U.S. drugmaker on Thursday said it had earned $501 million, or 47 cents per share, in the third quarter. Sales fell 16 percent to $4.88 billion, but topped...

  • Patent expirations hit Eli Lilly 3Q profit Thursday, 23 Oct 2014 | 6:39 AM ET

    NEW YORK— Eli Lilly and Co. said Thursday that its net income and sales sank in the third quarter after its antidepressant Cymbalta lost patent protection and faced competition from less-expensive generics. The Indianapolis company said its net income fell 58 percent to $500.6 million, or 47 cents per share. Zacks Investment Research says analysts expected...

  • Final Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 6:09 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $68.37. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $51.84. Hospira fell$. 80 or 1.6 percent, to $50.08.

  • Eli Lilly adds $375M to Zymeworks partnership Wednesday, 22 Oct 2014 | 5:12 PM ET

    NEW YORK— Eli Lilly and Zymeworks said Wednesday they are expanding a cancer drug development partnership. Without explaining the initial terms of the partnership, the companies said Zymeworks could get an additional $375 million in milestones and other payments. Shares in Indianapolis- based Eli Lilly and Co. were unchanged at $64.68 on Wednesday.

  • Midday Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 1:18 PM ET

    Baxter International Inc. fell$. 24 or. 3 percent, to $68.41. Bristol-Myers Squibb Co. fell$. 01 or percent, to $51.94. Hospira rose$. 09 or. 2 percent, to $50.97.

  • Early Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 10:36 AM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $68.82. Bristol-Myers Squibb Co. rose$. 02 or percent, to $51.97. Hospira rose$. 06 or. 1 percent, to $50.94.

  • Final Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 6:01 PM ET

    Baxter International Inc. rose$. 71 or 1.0 percent, to $68.65. Bristol-Myers Squibb Co. rose $1.39 or 2.7 percent, to $51.95. Hospira rose $1.01 or 2.0 percent, to $50.88.

  • Midday Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 1:43 PM ET

    Baxter International Inc. rose$. 28 or. 4 percent, to $68.22. Bristol-Myers Squibb Co. rose$. 81 or 1.6 percent, to $51.37. Hospira rose$. 24 or. 5 percent, to $50.11.

  • Early Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 11:56 AM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $68.01. Bristol-Myers Squibb Co. rose$. 42 or. 8 percent, to $50.98. Hospira rose$. 22 or. 4 percent, to $50.09.

  • Final Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 6:05 PM ET

    Baxter International Inc. rose$. 70 or 1.0 percent, to $67.94. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $50.56. Hospira fell$. 20 or. 4 percent, to $49.87.

  • Midday Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 18 or. 3 percent, to $67.42. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $50.25. Hospira fell$. 18 or. 4 percent, to $49.89.

  • Early Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 10:40 AM ET

    Baxter International Inc. rose$. 02 or percent, to $67.26. Bristol-Myers Squibb Co. rose$. 03 or. 1 percent, to $50.45. Hospira rose$. 25 or. 5 percent, to $50.32.

  • Final Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 94 or 1.4 percent, to $67.24. Bristol-Myers Squibb Co. rose $1.20 or 2.4 percent, to $50.42. Hospira rose$. 40 or. 8 percent, to $50.07.